ClinicalTrials.Veeva

Menu

Smartwatch ABPM vs. Conventional ABPM (SamsungWatch)

W

Wonju Severance Christian Hospital

Status

Completed

Conditions

Blood Pressure

Treatments

Device: Ambulatory blood pressure monitoring
Device: Galaxy Watch Active2

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT04553861
SamsungWatch

Details and patient eligibility

About

This study aims to investigate the accuracy and precision of the Samsung Smartwatch with conventional ambulatory blood pressure monitoring in healthy volunteers.

Full description

Blood pressure (BP) monitoring outside of the medical care environment is an increasingly important part of clinical hypertension assessment and management. Ambulatory BP monitoring (ABPM) uses automatic detection and recording devices for repeated determinations during an extended period, typically 24 hours. This technique has been shown to substantially enhance the clinician's understanding of BP behavior in patients and aid in diagnosis and therapeutic decision making. The ABPM is superior to office BP in predicting target organ, hypertensive cerebrovascular disease, retinopathy, renal abnormalities, and alterations in vascular compliance.1-4) Most of these studies have also demonstrated that a loss of nocturnal decline in BP (so-called non-dipper) conveys excessive risk for stroke and myocardial infarction.

Although conventional ABMP is usually well tolerated by patients, a few problems do exist. A minority of patients do not sleep well with the recorders and tend to have somewhat higher BP values. Cuffs can also rotate, and different arm positions can change BP significantly. Rarely, patients may develop erythema, ecchymoses, petechiae, or superficial phlebitis in the area distal to cuff placement.

Recently, smartwatches that measure BP without a cuff have become available. Since these measurements are relatively more user-friendly than conventional cuff-based measurements, they may aid in more frequent BP monitoring. Currently, only one study compared a non-commercial armband wearable pulse transit time (PTT) system for 24-hour cuff-less BP measurement with ABPM.5) We will investigate the accuracy and precision of Samsung Smartwatch with ABPM in young, healthy volunteers.

Enrollment

30 patients

Sex

All

Ages

20+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria

  • Ambulatory healthy subjects
  • Subjects aged 20 years or more
  • Subjects willing to participate in this study voluntarily Exclusion criteria
  • Subjects inability to provide informed consent
  • Subjects with any medical history
  • Subjects with irregular heart rhythm (e.g. atrial fibrillation, atrial flutter, or bigeminy)
  • Subjects unable to wear a watch due to wrist circumference
  • Subjects with BP difference 10mmHg or more between left and right arm

Trial design

30 participants in 1 patient group

Healthy subjects
Description:
Healthy subjects without blood pressure difference on both arm
Treatment:
Device: Ambulatory blood pressure monitoring
Device: Galaxy Watch Active2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems